Doptelet (Avatrombopag)

Save over 65% with Doptelet from Europe.

Non-english packaging - English label and English insert included. Plan in advance - allow us 7 days to ship your medicine

Manufacturer for Europe Swedish Orphan Biovitrum AB (publ) Strandbergsgatan 49, Stockholm, 112 51 Sweden

Information about Doptelet (Avatrombopag)

Doptelet, known generically as Avatrombopag, is a medication used primarily to treat low platelet counts (thrombocytopenia) in patients with chronic liver disease who are scheduled for a procedure. It is a thrombopoietin receptor agonist that stimulates platelet production.

Product Highlights

• Treatment of thrombocytopenia in adults with chronic liver disease who are at risk for bleeding or require a procedure.
• Increases platelet counts within a few days of administration.

Key Ingredient

• Avatrombopag

Key Benefits

• Effectively raises platelet levels, reducing the risk of bleeding.
• Simple once-daily regimen.
• Rapidly elevates platelet counts in preparation for medical procedures.

Direction of Use

• Take Doptelet as prescribed by a healthcare provider. 
• It can be taken either with food or without. 
• It is recommended to take the medication at the same time each day for consistency.

Suggested Dose and Duration for Patients with Chronic Liver Disease Preparing for a Procedure:

DOPTELET has been studied solely as a once-daily dosing regimen over a 5-day period in clinical trials with patients who have chronic liver disease. It should not be used in patients with chronic liver disease to attempt to normalize platelet counts.

Safety Concerns

• May include headache, fatigue, nausea, and liver enzyme elevations.
• Regular monitoring of platelet counts and liver function tests is advised.

Avoid Doptelet (Avatrombopag) If

• You have a history of hypersensitivity to Avatrombopag or any of its components.
• You have active or uncontrolled bleeding disorders.
• You are taking certain medications that may interact adversely with Doptelet.